While MitoTam suppressed tumour progression [35], we did not find any significant increase in transcripts of senescence markers p16Ink4a, p21waf1 and PAI in tumours of MitoTam-treated mice (Fig. 1c) or in β-galactosidase activity (Fig. 1d). The gene discussed is CDKN2A; the disease is neoplasm.